| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.6M | — | +8.4% |
| Cost of Revenue | $2.3M | — | +15.3% |
| Gross Profit | $8.3M | — | +6.6% |
| R&D Expense | $1.1M | — | -3.7% |
| SG&A Expense | $5.2M | — | +35.7% |
| Operating Income | -$1.9M | — | -100.3% |
| Net Income | -$2.1M | — | -43.9% |
| EPS (Basic) | -$0.17 | — | -41.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.6M | +61.9% | +3.6% |
| Accounts Receivable | $6.3M | -4.0% | -0.6% |
| Current Assets | $15.9M | +25.8% | +3.3% |
| Total Assets | $35.1M | +8.9% | +6.0% |
| Current Liabilities | $15.4M | +7.1% | +30.9% |
| Long-term Debt | $16.6M | +23.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.3M | — | +2963.6% |
| Capital Expenditures | $17K | — | +466.7% |
| Investing Cash Flow | -$727K | — | +8.0% |
| Financing Cash Flow | $2.7M | — | -20.5% |
| Free Cash Flow | $1.2M | — | +2744.7% |
| +38.4% |
| Total Liabilities | $31.9M | +16.4% | +26.8% |
| Stockholders' Equity | $3.2M | -33.8% | -60.0% |